Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
While automated solid-phase synthesis of peptides and oligonucleotides is well established, the preparation of oligosaccharides on solid support still remains challenging. The first two biooligomer families are based on linear backbones and are composed of monomers that differ only in their side chains or nucleobases, and no formation of a stereogenic center is involved in the coupling step. Oligosaccharides, in contrast, are usually branched, since sugar units with varying functionalization are linked at different positions, in a linear or branched manner, and with alternating stereochemistry.The advantages of solid-phase chemistry, such as the improvement of yield made possible by the use of excess of reagents, or the separation of reactants and side products, should also be of interest in oligosaccharide synthesis. Important for a successful oligosaccharide solidphase synthesis are the choice of the appropriate resin and linker, a suitable protecting group strategy, and the provision of a high-yielding, stereospecific coupling reaction. The sugar donor or acceptor can be applied either as the resin-bound component, or in excess as the reagent. The detection of successful coupling on solid support is of particular importance for the development of a solid-phase synthesis. Coupling of oligosaccharides remains more difficult to analyze than chain-elongation of peptides or oligonucleotides, because the coupling yield can not be determined simply from the concentration of cleaved protecting groups. In addition, the newly established stereocenter has to be considered. The use of enzymes for coupling of sugar units on solid support is especially valuable for control of regioselectivity and stereochemistry.Some further examples of promising approaches towards the solid-phase synthesis of oligosaccharides are reported in [ 11.Organic Synthesis Highlights V Edited by Hans-
While automated solid-phase synthesis of peptides and oligonucleotides is well established, the preparation of oligosaccharides on solid support still remains challenging. The first two biooligomer families are based on linear backbones and are composed of monomers that differ only in their side chains or nucleobases, and no formation of a stereogenic center is involved in the coupling step. Oligosaccharides, in contrast, are usually branched, since sugar units with varying functionalization are linked at different positions, in a linear or branched manner, and with alternating stereochemistry.The advantages of solid-phase chemistry, such as the improvement of yield made possible by the use of excess of reagents, or the separation of reactants and side products, should also be of interest in oligosaccharide synthesis. Important for a successful oligosaccharide solidphase synthesis are the choice of the appropriate resin and linker, a suitable protecting group strategy, and the provision of a high-yielding, stereospecific coupling reaction. The sugar donor or acceptor can be applied either as the resin-bound component, or in excess as the reagent. The detection of successful coupling on solid support is of particular importance for the development of a solid-phase synthesis. Coupling of oligosaccharides remains more difficult to analyze than chain-elongation of peptides or oligonucleotides, because the coupling yield can not be determined simply from the concentration of cleaved protecting groups. In addition, the newly established stereocenter has to be considered. The use of enzymes for coupling of sugar units on solid support is especially valuable for control of regioselectivity and stereochemistry.Some further examples of promising approaches towards the solid-phase synthesis of oligosaccharides are reported in [ 11.Organic Synthesis Highlights V Edited by Hans-
Real-time protein detection in homogeneous solutions is necessary in many biotechnology and biomedical studies. The recent development of molecular aptamers, combined with fluorescence techniques, may provide an easy and efficient approach to protein elucidation. This report describes the development of a fluorescence-based assay with synthetic DNA aptamers that can detect and distinguish molecular variants of proteins in biological samples in a high-throughput process. We used an aptamer with high affinity for the B chain of platelet-derived growth factor (PDGF), labeled it with a fluorophore and a quencher at the two termini, and measured fluorescence quenching by PDGF. The specific quenching can be used to detect PDGF at picomolar concentrations even in the presence of serum and other cell-derived proteins in cell culture media. This is the first successful application of a synthetic aptamer for the detection of tumor-related proteins directly from the tumor cells. We also show that three highly related molecular variants of PDGF (AA, AB, and BB dimers) can be distinguished from one another in this single-step assay, which can be readily adapted to a microtiter plate assay for high-throughput analysis. The use of fluorescence quenching as a measure of binding between the DNA probe and the target protein eliminates potential false signals that may arise in traditional fluorescence enhancement assays as a result of degradation of the DNA aptamer by contaminating nucleases in biological specimens. This assay is applicable to proteins that are not naturally DNA binding. The excellent specificity, ultrahigh sensitivity, and simplicity of this one-step assay addresses a growing need for high-throughput methods that detect changes in the expression of gene products and their variants in cell cultures and biological specimens.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.